The NKP valuation is harder to do
If they develop this then there would be a massive dilution if they are going to raise say the $1 billion that they need.
Even with a JV this would affect the valuation too... obviously this would take out vertain risks as well
I see a $2.50 target price for NKP in 12-18 months.
Until a corporate play is revealed to the market then I think a $10+ long term valuation is abit too much
I know platinum prices are high and market conditions look great but beingconservative is the way
My sentiment for NKP is a LT buy is because the seem to need to get IGC issue resolved whatever that may be... JV, merger, takeover etc
Just my opionion
- Forums
- ASX - By Stock
- NKP
- top 5
top 5 , page-5
Featured News
Add NKP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online